The Section of Cell Therapy

Dag Josefsen
Department head

The Department of Cellular Therapy is home to one of Europe’s biggest and most modern GMP facilities for cellular products and is currently also involved in producing cellular products for a clinical trial in Munich. The large scale GMP-certified T-cell culture technique developed at this facility will also constitute the backbone for the planned Phase I/II clinical trials in adoptive T-cell therapy.

In addition the Department of Cellular Therapy has concentrated its translational research activities in the clinical research group which is comprised of the Immunomonitoring Unit and the Molecular Biology service (Dept. of Cellular Therapy/Dept. of Immunology-Lymphoma group).
The Immunomonitoring Unit is responsible for testing of immune responses in vaccinated cancer patients as well as running functional assays and pre-clinical in vivo studies of redirected T cells. The Molecular Biology service works hand in hand with the Immunomonitoring Unit and collect the patient material that can be used to isolate potential therapeutic antigen receptors.

 

We are looking for a motivated Master student !

Immunotherapy & Biotechnology: Validation of humanized Chimeric Antigen Receptors targeted against solid tumour

A Master position is available for 2021 at the Unit of Translational Research, Department of Cellular Therapy, Oslo University Hospital (OUS) Radiumhospitalet under the supervision of Sébastien Wälchli (Senior researcher, group leader).

We offer: (1) a position in a dynamic environment within a modern/fully equipped facility (Oslo Cancer Cluster Incubator next to Radium hospital) and (2) the possibility to use advanced technology.

Successful candidates might be sent to an international conference.

Find out more here !

Any questions about the position can be sent to the following e-mail address: sebastw@rr-research.no

News

Make sure to have a look at our recent activities! 

All news